Catalyst Pharmaceuticals (CPRX) P/E (2011 - 2026)
Catalyst Pharmaceuticals (CPRX) P/E from Mar 31, 2011 to Jul 16, 2026. The TTM Catalyst Pharmaceuticals (CPRX) P/E is 17.44. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Catalyst Pharmaceuticals (CPRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 17.44 | +30.71% |
| 2025 | 13.34 | -12.28% |
| 2024 | 15.21 | -46.88% |
| 2023 | 28.63 | -0.23% |
| 2022 | 28.70 | +62.10% |
| 2021 | 17.70 | +283.66% |
| 2020 | 4.61 | -61.95% |
| 2019 | 12.13 | -309.21% |
| 2018 | -5.80 | -69.61% |
| 2017 | -19.08 | +332.58% |
| 2016 | -4.41 | -55.80% |
| 2015 | -9.98 | -18.34% |
| 2014 | -12.22 | +57.98% |
| 2013 | -7.73 | +132.61% |
| 2012 | -3.32 | -49.81% |
| 2011 | -6.62 | N/A |
Comparison Catalyst Pharmaceuticals (CPRX) P/E with competitors
Catalyst Pharmaceuticals (CPRX) P/E is 17.44.